PAGAN ELEONORA

Peradze, N., Polizzi, A., Pagan, E., Bottazzoli, E., Bagnardi, V., Sangalli, C., et al. (2025). Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 51(6 (June 2025)) [10.1016/j.ejso.2025.109714]. Detail

Conforti, F., Nekljudova, V., Sala, I., Ascari, R., Solbach, C., Untch, M., et al. (2025). Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer. JOURNAL OF CLINICAL ONCOLOGY, 43(12), 1441-1452 [10.1200/JCO-24-01360]. Detail

Vicini, E., Galimberti, V., Leonardi, M., Kahler-Ribeiro-Fontana, S., Polizzi, A., Petitto, S., et al. (2025). Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients. BREAST CANCER RESEARCH AND TREATMENT, 210(3), 661-672 [10.1007/s10549-024-07604-3]. Detail

Pala, L., Merlo, F., Sala, I., Pagan, E., Oriecuia, C., Specchia, C., et al. (2025). Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates. JOURNAL OF THE NATIONAL CANCER INSTITUTE [10.1093/jnci/djaf049]. Detail

Sala, I., Pagan, E., Pala, L., Oriecuia, C., Musca, M., Specchia, C., et al. (2024). Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis. FRONTIERS IN IMMUNOLOGY, 15 [10.3389/fimmu.2024.1340979]. Detail